hsa-mir-625: Hsa-mir-625 is a microRNA that has been found to be down-regulated in various conditions, including Alzheimer's disease (AD) [PMC3205057]. It is one of the microRNAs predicted to target multiple genes associated with AD [PMC9312389]. Hsa-mir-625 has also been identified as one of the miRNAs that can be used to distinguish different types of lymphomas [PMC4335255]. Additionally, it has been found to be differentially expressed in various cancers, including breast cancer [PMC6412941] and pancreatic cancer [PMC7942015]. The upregulation of hsa-mir-625 has been investigated for its effect on apoptosis and proliferation in a specific cell line [PMC9375600]. In human oocytes, hsa-mir-625 was found to be up-regulated in mature oocytes compared to immature ones [PMC4919285]. The variant deletion allele of hsa-mir-625 has been associated with changes in its minimum free energy (MFE) and potential target sites for other miRNAs have been identified within its sequence [PMC3444488] [PMC4008537]. Hsa-mir-625 is also mentioned as one of the miRNA precursors with previously unreported antisense transcripts [PMC3722126]. Finally, it has been identified as one of the RNA molecules transferred from pancreatic cancer cells to osteoblasts via small extracellular vesicles (sEVs) for intercellular communication [PMC8056276].
MIR625: MIR625 is a microRNA that is down-regulated when Dicer is down-regulated, leading to decreased production of several miRNAs [PMC3316564]. Decreased expression of MIR625 has been observed in colorectal carcinoma [PMC7137242]. In colorectal carcinoma, MIR625 is associated with decreased survival rates [PMC7137242].
Sequence features are shown above as colored rectangles. Zoom in and click to view details, or Reset
View annotations in different species by clicking on species names.
Scroll around to explore the entire tree. Click tree nodes to collapse or expand them. Hover over taxon names to display additional information.